triamcinolone diacetate 40 MG/ML Injectable Suspension
- RxCUI
- 1085680
- RxNorm name
- triamcinolone diacetate 40 MG/ML Injectable Suspension
- Term type
- SCD
- Status
- Active
- Updated
- 2026-06-14 07:04:37
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 022011
- Active start
- 022011
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| triamcinolone diacetate | 40 MG / 1 ML | triamcinolone | triamcinolone diacetate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Injectable Suspension | 316950 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| triamcinolone | 10759 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| RXNAV_STR | triamcinolone diacetate 40 MG/ML Injectable Suspension | 1 | NAMES |
| RxNorm Name | triamcinolone diacetate 40 MG/ML Injectable Suspension | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| RxCUI | 1085680 | 1 | CODES |
| MMSL_CODE | 3 | CODES |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KENALOG-40 | TRIAMCINOLONE ACETONIDE | E.R. Squibb & Sons, L.L.C. | cf970688-cd77-b95c-4bd9-c541590e9722 | 2024-08-20 | Warnings, Adverse reactions | 00003029320 00003029305 00003029328 |
DailyMed RxNorm Mappings#
No records found.
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 3f045347-3e5e-4bbd-90f8-6c3100985ca5 | These highlights do not include all the information needed to use TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE ® suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 1957 | Alcon Laboratories, Inc. | Alcon Research LLC | 20240916 |
| cf970688-cd77-b95c-4bd9-c541590e9722 | KENALOG ® -40 INJECTION KENALOG ® -80 INJECTION (triamcinolone acetonide injectable suspension, USP) | E.R. Squibb & Sons, L.L.C. | 20240820 |
| 1186a600-682d-407d-9579-9aba8f9f0a88 | Triamcinolone Acetonide Injectable Suspension, USP | Sandoz Inc | 20181008 |
| 1156c8a9-e2c1-49cb-b395-93959820c14f | KENALOG ® -40 INJECTION (triamcinolone acetonide injectable suspension, USP) | Proficient Rx LP | 20140204 |
| d4048a8e-0fe8-4185-b23e-386eb38c2337 | National Council for Prescription Drug Programs | 20130213 | |
| 0d61ba7b-8aba-4569-8334-5d24bbf99578 | KENALOG ® -40 INJECTION (triamcinolone acetonide injectable suspension, USP) | Dispensing Solutions, Inc. | 20120914 |
| 153f36e3-58f9-4d0a-88d8-aaf3e2593269 | National Council for Prescription Drug Programs | 20120724 | |
| 400c3ac9-8635-4cb6-9d8c-b4b13303e9fb | National Council for Prescription Drug Programs | 20120724 | |
| 8b6efe30-f13f-4c07-b0d0-80260e9caec6 | National Council for Prescription Drug Programs | 20120724 | |
| b78e952b-4a4f-4dbb-ac97-bf155b97b10e | National Council for Prescription Drug Programs | 20120724 | |
| b854e809-27b7-4afc-9b15-88f02ad6b1a6 | National Council for Prescription Drug Programs | 20120724 | |
| c97ffb6b-a47c-4d7a-a126-321cd7db83c5 | National Council for Prescription Drug Programs | 20120724 | |
| cc7f114f-5ccf-44aa-a58a-964d4816445d | National Council for Prescription Drug Programs | 20120724 | |
| d53c1531-3864-4d07-8af2-31f7b5529d5c | KENALOG ® -40 INJECTION triamcinolone acetonide injectable suspension, USP | Physicians Total Care, Inc. | 20101101 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C05AA | Corticosteroids | ATC1-4 | triamcinolone | |
| ATC | R01AD | Corticosteroids | ATC1-4 | triamcinolone | |
| ATC | A01AC | Corticosteroids for local oral treatment | ATC1-4 | triamcinolone | |
| ATC | D07AB | Corticosteroids, moderately potent (group II) | ATC1-4 | triamcinolone | |
| ATC | D07XB | Corticosteroids, moderately potent, other combinations | ATC1-4 | triamcinolone | |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | triamcinolone | |
| ATC | R03BA | Glucocorticoids | ATC1-4 | triamcinolone | |
| ATC | H02AB | Glucocorticoids | ATC1-4 | triamcinolone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | triamcinolone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | triamcinolone |
| MEDRT | D014221 | Triamcinolone | CHEM | has_ingredient | triamcinolone |
| MEDRT | D014221 | Triamcinolone | CHEM | has_ingredient | triamcinolone diacetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | triamcinolone |
| MEDRT | D000743 | Anemia, Hemolytic | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D000743 | Anemia, Hemolytic | DISEASE | may_treat | triamcinolone |
| MEDRT | D015210 | Arthritis, Gouty | DISEASE | may_prevent | triamcinolone |
| MEDRT | D015210 | Arthritis, Gouty | DISEASE | may_prevent | triamcinolone diacetate |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_prevent | triamcinolone |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_prevent | triamcinolone diacetate |
| MEDRT | D001249 | Asthma | DISEASE | may_prevent | triamcinolone |
| MEDRT | D001249 | Asthma | DISEASE | may_prevent | triamcinolone diacetate |
| MEDRT | D001607 | Berylliosis | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D001607 | Berylliosis | DISEASE | may_treat | triamcinolone |
| MEDRT | D001986 | Bronchial Spasm | DISEASE | may_treat | triamcinolone |
| MEDRT | D001986 | Bronchial Spasm | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | triamcinolone |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D003874 | Dermatitis Herpetiformis | DISEASE | may_treat | triamcinolone |
| MEDRT | D003874 | Dermatitis Herpetiformis | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | triamcinolone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | triamcinolone diacetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | triamcinolone |
| MEDRT | D004892 | Erythema Multiforme | DISEASE | may_treat | triamcinolone |
| MEDRT | D004892 | Erythema Multiforme | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | triamcinolone |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | triamcinolone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | triamcinolone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D006934 | Hypercalcemia | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D006934 | Hypercalcemia | DISEASE | may_treat | triamcinolone |
| MEDRT | D007239 | Infections | DISEASE | ci_with | triamcinolone diacetate |
| MEDRT | D007239 | Infections | DISEASE | ci_with | triamcinolone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | triamcinolone |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | triamcinolone |
| MEDRT | D008180 | Lupus Erythematosus, Systemic | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D008180 | Lupus Erythematosus, Systemic | DISEASE | may_treat | triamcinolone |
| MEDRT | D009103 | Multiple Sclerosis | DISEASE | may_treat | triamcinolone |
| MEDRT | D009103 | Multiple Sclerosis | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | triamcinolone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | triamcinolone diacetate |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D009404 | Nephrotic Syndrome | DISEASE | may_treat | triamcinolone |
| MEDRT | D010392 | Pemphigus | DISEASE | may_treat | triamcinolone |
| MEDRT | D010392 | Pemphigus | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | triamcinolone |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | triamcinolone |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | triamcinolone |
| MEDRT | D012713 | Serum Sickness | DISEASE | may_treat | triamcinolone |
| MEDRT | D012713 | Serum Sickness | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D013167 | Spondylitis, Ankylosing | DISEASE | may_treat | triamcinolone |
| MEDRT | D013224 | Status Asthmaticus | DISEASE | ci_with | triamcinolone |
| MEDRT | D013224 | Status Asthmaticus | DISEASE | ci_with | triamcinolone diacetate |
| MEDRT | D013585 | Synovitis | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D013585 | Synovitis | DISEASE | may_treat | triamcinolone |
| MEDRT | D013966 | Thyroiditis | DISEASE | may_treat | triamcinolone |
| MEDRT | D013966 | Thyroiditis | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D014397 | Tuberculosis, Pulmonary | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | D014397 | Tuberculosis, Pulmonary | DISEASE | may_treat | triamcinolone |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | triamcinolone |
| MEDRT | D014605 | Uveitis | DISEASE | may_treat | triamcinolone diacetate |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | triamcinolone diacetate |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | triamcinolone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | triamcinolone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | triamcinolone diacetate |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | triamcinolone diacetate |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | triamcinolone |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | triamcinolone |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | triamcinolone diacetate |
| MEDRT | N0000008571 | Decreased Cytokine Activity | PE | has_pe | triamcinolone diacetate |
| MEDRT | N0000008571 | Decreased Cytokine Activity | PE | has_pe | triamcinolone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | triamcinolone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | triamcinolone diacetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | triamcinolone diacetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | triamcinolone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | triamcinolone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | triamcinolone diacetate |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | triamcinolone diacetate |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | triamcinolone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | triamcinolone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | triamcinolone diacetate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | triamcinolone diacetate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | triamcinolone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | triamcinolone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | triamcinolone diacetate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | triamcinolone diacetate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | triamcinolone |
| MEDRT | N0000009741 | Lysosomal Function Alteration | PE | has_pe | triamcinolone |
| MEDRT | N0000009741 | Lysosomal Function Alteration | PE | has_pe | triamcinolone diacetate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| CODES | SNOMEDCT | 375176003 |
| CODES | VUID | 4001619 |
| SOURCES | Source | US Edition of SNOMED_CT |